Jane Street’s Collegium Pharmaceutical COLL Stock Holding History

Jane Street’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,500	Closed	-$560K	–	9528
2024 Q3	$560K	Hold	14,500	–	–	﹤0.01%	6993
2024 Q2	$467K	Hold	14,500	–	–	﹤0.01%	7130
2024 Q1	$563K	Buy	+14,500	New	+$507K	﹤0.01%	6451
2023 Q4	–	Sell	-10,000	Closed	-$224K	–	9243
2023 Q3	$224K	Buy	+10,000	New	+$228K	﹤0.01%	7473
2023 Q1	–	Sell	-25,000	Closed	-$580K	–	9140
2022 Q4	$580K	Hold	25,000	–	–	﹤0.01%	5872
2022 Q3	$401K	Buy	+25,000	New	+$441K	﹤0.01%	7087

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Jane Street's COLL Position: Q1 2026 in Review

Jane Street sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 190,763 shares — an estimated $8.83M sold.

Jane Street first reported a position in COLL in Q3 2020 and held it in 14 quarters. The position peaked at $8.83M in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

Jane Street reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
Jane Street sold 190,763 Collegium Pharmaceutical shares in Q1 2026, an estimated $8.83M.
Jane Street first reported a position in Collegium Pharmaceutical in Q3 2020 and held it in 14 quarters.
Jane Street's Collegium Pharmaceutical position peaked at $8.83M in Q4 2025.
266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.